James M. Pluda
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Co-authors
- Robert YarchoanHiroaki MitsuyaKathleen M. WyvillSamuel BroderRose V. ThomasSeth M. SteinbergS BroderDavid G. Johns
- Journals
- Journal of Clinical Oncology (17 papers)The Journal of Infectious Diseases (5 papers)Cancer (4 papers)Annals of Oncology (3 papers)Annals of Internal Medicine (3 papers)
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
James M. Pluda
87 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 132
- Virology 1.0k
- Infectious Diseases 1.4k
- Oncology 2.0k
- Genetics 743
- Cancer Research 1.0k
Countries citing papers authored by James M. Pluda
This map shows the geographic impact of James M. Pluda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Pluda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Pluda more than expected).
Fields of papers citing papers by James M. Pluda
This network shows the impact of papers produced by James M. Pluda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Pluda. The network helps show where James M. Pluda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James M. Pluda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 12 | |
| 2 | A phase I pharmacokinetic and pharmacodynamic study of SU5416 and Adriamycin in inflammatory breast cancer | 2001 | 13 |
| 3 | 2001 | 56 | |
| 4 | 2001 | 13 | |
| 5 | 2001 | 40 | |
| 6 | 2000 | 19 | |
| 7 | 1999 | 106 | |
| 8 | 1998 | 99 | |
| 9 | 1998 | 160 | |
| 10 | 1996 | 26 | |
| 11 | 1996 | 23 | |
| 12 | 1995 | 40 | |
| 13 | 1994 | 64 | |
| 14 | 1994 | 13 | |
| 15 | 1993 | 27 | |
| 16 | 1992 | 65 | |
| 17 | 1991 | 45 | |
| 18 | 1990 | 54 | |
| 19 | 1990 | 213 | |
| 20 | 1990 | 14 |
About James M. Pluda
James M. Pluda is a scholar working on Virology, Oncology, Genetics, Hematology and Pathology and Forensic Medicine, having authored 87 papers that have together received 6.0k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (22 papers), Lymphoma Diagnosis and Treatment (20 papers), HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers), Angiogenesis and VEGF in Cancer (13 papers), Multiple Myeloma Research and Treatments (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and Cancer Treatment and Pharmacology (12 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (1.4k citations), Oncology (2.0k citations), Genetics (743 citations) and Cancer Research (1.0k citations). James M. Pluda has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Robert Yarchoan, Hiroaki Mitsuya, Kathleen M. Wyvill, Samuel Broder, Rose V. Thomas, Seth M. Steinberg, S Broder, David G. Johns, Richard Kaplan and William D. Figg. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Infectious Diseases, Cancer, Annals of Oncology and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.